Escitalopram Oxalate

CAS 219861-08-2 26 current records 6 historicalSmall Molecule

Who holds supplier records for Escitalopram Oxalate? 26 organisations hold a current record for Escitalopram Oxalate: an active US FDA Type II Drug Master File or a CEP. A further 6 organisations have only historical (inactive) DMF filings. 18 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (20), China (2) and Italy (1); not recorded for 3.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Escitalopram Oxalate: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/escitalopram-oxalate

Reading the evidence

  • 26 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    20 of the 23 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 12 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (26)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Escitalopram Oxalate. Country is the organisation's recorded country, not necessarily the manufacturing site.

India20China2Italy1Country not recorded for 3
Need Escitalopram Oxalate sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (18)

Certificates of Suitability on the EDQM register for Escitalopram Oxalate, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 28 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
SHODHANA LABORATORIES PRIVATE LIMITED Medchal MalkajgiriIN
CEP 2018-278 - Rev 02
Escitalopram oxalate
Oct 2026—
MAITHRI LABORATORIES PRIVATE LIMITED Gaddapotharam VillageIN
CEP 2025-247 - Rev 00
Escitalopram oxalate, Milled and non-milled
Oct 2026—
SYNERGENE ACTIVE INGREDIENTS PRIVATE LIMITED HyderabadIN
CEP 2025-192 - Rev 00
Escitalopram oxalate
Aug 2026—
RUYUAN HEC PHARM CO., LTD. ShaoguanCN
CEP 2020-258 - Rev 01
Escitalopram oxalate
Aug 2026—
NEULAND LABORATORIES LIMITED HyderabadIN
CEP 2021-161 - Rev 04
Escitalopram oxalate, Process-III
Aug 2026—
SMS PHARMACEUTICALS LIMITED HyderabadIN
CEP 2025-082 - Rev 00
Escitalopram oxalate
May 2026—
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. TaizhouCN
CEP 2016-178 - Rev 02
Escitalopram oxalate, Micronised, milled and non-micronised
Jan 2026Inspected May 2026
Italy
JUBILANT BIOSYS LIMITED NanjangudIN
CEP 2017-082 - Rev 01
Escitalopram oxalate
Oct 2025—
MATRIX PHARMACORP PRIVATE LIMITED Sangareddy DistrictIN
CEP 2019-130 - Rev 04
Escitalopram oxalate, Process II
Sept 2025—
MICRO LABS LIMITED BengaluruIN
CEP 2016-250 - Rev 02
Escitalopram oxalate
May 2025—
HETERO LABS LIMITED HyderabadIN
CEP 2016-306 - Rev 01
Escitalopram oxalate, Process I
May 2025—
SMILAX LABORATORIES LIMITED HyderabadIN
CEP 2023-012 - Rev 00
Escitalopram oxalate
Oct 2024—
OLON S.P.A. RodanoIT
CEP 2018-126 - Rev 02
Escitalopram oxalate
Aug 2024Inspected Mar 2025
Italy
APITORIA PHARMA PRIVATE LIMITED HyderabadIN
CEP 2021-321 - Rev 02
Escitalopram oxalate, Process II
Jul 2024—
VENKAR CHEMICALS PVT. LTD. HyderabadIN
CEP 2022-163 - Rev 00
Escitalopram oxalate
Jun 2024—
CIPLA LIMITED MumbaiIN
CEP 2023-413 - Rev 00
Escitalopram oxalate, Process-II
May 2024—
VIRUPAKSHA ORGANICS LIMITED HyderabadIN
CEP 2022-032 - Rev 00
Escitalopram oxalate
May 2024—
DR. REDDY'S LABORATORIES LIMITED HyderabadIN
R0-CEP 2019-222 - Rev 01
Escitalopram oxalate
Jun 2023—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (6)

Organisations whose Type II DMFs for Escitalopram Oxalate are no longer active. These show a past filing, not current supply.

Show all 6 historical records

US product patents and exclusivity

The FDA Orange Book lists patents and exclusivities for specific approved products (30 listed products contain Escitalopram Oxalate). The latest listed exclusivity ended 16 Sept 2026. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Escitalopram Oxalate is an antidepressant belonging to the selective serotonin reuptake inhibitor (SSRI) class. It is primarily used to treat major depressive disorder and generalized anxiety disorder.

Chemical identity

IUPAC name
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile
Canonical SMILES
CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F
InChIKey
WSEQXVZVJXJVFP-UHFFFAOYSA-N
Synonyms
Lexapro API, citalopram, Nitalapram, Cipram, Citalopramum, Citadur, Lu 10-171, CHEBI:77397, Cytalopram, RefChem:5691, CHEBI:3723, N06AB04

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Serotonin Reuptake Inhibitor
Mechanism of action
Serotonin Uptake Inhibitors

Therapeutic areas

PsychiatryNeurology

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Escitalopram Oxalate?

26 organisations hold an active US FDA Type II Drug Master File or a CEP for Escitalopram Oxalate: Cipla Limited (India), Hetero Labs Limited (India), JUBILANT BIOSYS LTD (India), APITORIA PHARMA PRIVATE LTD (India), Dr. Reddy's Laboratories Ltd. (India), Maithri Laboratories Private Limited (India), MATRIX PHARMACORP PRIVATE LTD (India) and MICRO LABS LTD (India), and 18 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Escitalopram Oxalate Drug Master Files are active?

Cipla Limited (DMF 16636, 38976), Hetero Labs Limited (DMF 17960, 26185), JUBILANT BIOSYS LTD (DMF 19446, 22864), APITORIA PHARMA PRIVATE LTD (DMF 19088), Dr. Reddy's Laboratories Ltd. (DMF 18342, 25873), Maithri Laboratories Private Limited (DMF 41315), MATRIX PHARMACORP PRIVATE LTD (DMF 18213) and MICRO LABS LTD (DMF 34568, 24684) and 15 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Escitalopram Oxalate records mean?

6 organisations have only inactive Type II DMFs for Escitalopram Oxalate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Escitalopram Oxalate have a European Certificate of Suitability?

Yes. 18 organisations hold a valid CEP for Escitalopram Oxalate on the EDQM register, including SHODHANA LABORATORIES PRIVATE LIMITED Medchal Malkajgiri (IN), MAITHRI LABORATORIES PRIVATE LIMITED Gaddapotharam Village (IN), SYNERGENE ACTIVE INGREDIENTS PRIVATE LIMITED Hyderabad (IN), RUYUAN HEC PHARM CO., LTD. Shaoguan (CN), NEULAND LABORATORIES LIMITED Hyderabad (IN) and SMS PHARMACEUTICALS LIMITED Hyderabad (IN) and 12 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Escitalopram Oxalate supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Escitalopram Oxalate?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.